Breaking
🇺🇸 FDA
2,317+ articles · 3 regulatory markets

Global Pharmaceutical News & Regulatory Intelligence

Breaking drug approvals, clinical trial results, and regulatory updates across FDA, EMA, and APAC agencies—published within hours.

Pharma Pulse

Aggregated from live regulatory feeds
183 FDA stories this week US regulatory coverage
26 M&A deals tracked Last 7 days
46 Trial & safety catalysts Phase readouts
124 EMA stories this week EU regulatory coverage
Editorial

Breaking intelligence

All news →
Help

Frequently Asked Questions

Coverage scope, editorial standards, and how we report regulatory news.

What regions does NovaPharma News cover?

We provide comprehensive pharmaceutical news and regulatory intelligence for three key markets: United States (FDA), European Union (EMA), and Asia-Pacific (NMPA/PMDA/TGA). Each region has dedicated coverage from local regulatory experts.

How quickly are new drug approvals reported?

Our editorial team monitors regulatory agency announcements in real-time. Breaking news on drug approvals, clinical trial results, and major regulatory decisions are typically published within hours of official announcements.

Who writes the articles on NovaPharma News?

All content is written and reviewed by credentialed pharmaceutical professionals including PharmDs, MDs, and regulatory affairs specialists with direct industry experience. Author credentials are displayed on every article.

Is NovaPharma News content peer-reviewed?

Yes. All articles undergo editorial review by subject matter experts before publication. We cite primary sources including official regulatory databases, peer-reviewed journals, and company press releases.